Internet of Things Based Remote Wearable Health Solutions: Prospects and Area of Research

Nanda, Shweta; Khattar, Kapil; Nanda, Saket

doi:10.2139/ssrn.3351034

Cited by 4 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As wearable systems are becoming important in routine clinical evaluations (Nanda, 2017) and internet of things is used for continuous monitoring and sharing of patient’s vitals (Nanda et al , 2019), the interoperability of medical data has gained pace. Blockchain technology can track the patient responses and improve the traceability of a clinical trial supply chain (Glover and Hermans, 2017).…”

Section: Introductionmentioning

confidence: 99%

Blockchain adoption in health market: a systems thinking and modelling approach

Nanda

2021

JABS

Self Cite

View full text Add to dashboard Cite

Purpose The purpose of this paper is to formulate strategic interventions that can contribute to adoption of blockchain in Asian health market. Design/methodology/approach A methodological framework based on the three qualitative phases of the systems thinking and modelling methodology, namely, problem structuring, causal loop modelling and developing strategic interventions were used. Data was collected using thirty interviews and secondary research. Findings The reference model developed in the study captured the system behavior, showing health market blockchain adoption increasing in other countries but struggling in Asia. The qualitative systems model developed explained this behavior by capturing the underlying system structure using six interconnected feedback loops. Three strategic interventions were formulated to change the system structure to improve its adoption. Research limitations/implications This study acknowledges its limitation that blockchain integration in health supply chain management (SCM) and adaptability to technological trends are just few elements that contributes to challenges in blockchain adoption in Asia Pacific health market . It also acknowledges the limited scale of this study using 30 interviews with a narrow set of stakeholders, limiting its generalisability. Practical implications Although the blockchain technology has medical data security benefits, its integration in health SCM could potentially improve cost of health service delivery to patient. Not only it prevents drug counterfeiting, it enhances patient’s safety by reducing the time it takes to alert the supply chain of a product recall from few days to few seconds. Social implications “Blockchain-as-a-Service” has wide applications in SCM, identity management, payments, smart contracts, governance risk and compliance management, with its market size expected to grow in future. This affordable solution opens up the roads for future empirical research for information systems academicians and information technology practitioners. Originality/value This research provides a holistic analysis of the challenges facing blockchain adoption in the health market for Asia. It offers a methodological approach based on systems thinking and modelling to improve its adoption.

show abstract

Section: Introductionmentioning

confidence: 99%

Blockchain adoption in health market: a systems thinking and modelling approach

Nanda

2021

JABS

Self Cite

View full text Add to dashboard Cite

show abstract

“…El imiquimod es un fármaco inmunomodulador, de la familia imidazoquinolina de bajo peso molecular, inhibe la replicación del VPH al estimular la respuesta innata y adaptativa, mediante la activación del receptor tipo toll 7 y el factor nuclear kappa-B en el sitio de aplicación del medicamento; estos receptores desencadenan la reducción de interferónalfa, el interferón-gamma, el factor de necrosis e interleucinas IL-1, IL-6, IL-8, las cuales activan las respuestas inmunitarias innata y adaptativa, inhibiendo la replicación del VPH; de esta manera, inducimos la regresión de las verrugas anogenitales (11); el grado de absorción es menor al 0.9%, con una concentración máxima en suero de 0.1 a 1.6 ng/ml se llega a excretar por vía urinaria y fecal en una relación 3:1; el tratamiento médico, después de la cirugía, consiste en un esquema de aplicación nocturna de 3 veces por semana en un intervalo de 6 a 10 horas; las complicaciones del TBL incluyen infecciones secundarias, abscesos, formación de fístulas, hemorragias, necrosis, recurrencias y en un 56% transformaciones malignas (1). La profilaxis contra el virus del papiloma humano (VPH) debe ser realizada mediante la vacuna, la cual protege un 90% contra verrugas genitales y un 70% contra cáncer cérvico-uterino (1).…”

unclassified

Cirugía más inmunoterapia local en el tratamiento del tumor de Buschke-Löwenstein. A propósito de un caso

Rojas Espinoza,

Torrico Vilte

2023

Rev. Inv. Inf. Sal.

View full text Add to dashboard Cite

El condiloma acuminado gigante o tumor de Buschke-Löwenstein (TBL) pertenece al grupo de carcinomas verrugosos. Su agente etiológico se encuentra en los virus del papiloma humano (VPH serotipos 6 y 11), caracterizándose por lesiones verrugosas gigantes de localización perineal. Presentamos el caso de un paciente masculino de 28 años diagnosticado con condiloma gigante de Buschke-Löwenstein, se realizó tratamiento quirúrgico agregando imiquimod topico como terapeutica adyuvante con excelente evolucion a largo plazo.

show abstract

Internet of Things Based Remote Wearable Health Solutions: Prospects and Area of Research

Cited by 4 publications

References 16 publications

Blockchain adoption in health market: a systems thinking and modelling approach

Blockchain adoption in health market: a systems thinking and modelling approach

Cirugía más inmunoterapia local en el tratamiento del tumor de Buschke-Löwenstein. A propósito de un caso

Emerging health start-ups for economic feasibility: opportunities during COVID-19

Contact Info

Product

Resources

About